Patents by Inventor Paige Roanne Palmer Brooks

Paige Roanne Palmer Brooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7205300
    Abstract: This invention is directed to compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: April 17, 2007
    Assignee: Pfizer Inc
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 7144882
    Abstract: This invention is directed to compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: December 5, 2006
    Assignee: Pfizer Inc
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 6951938
    Abstract: Pharmaceutical compositions comprising compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are defined as in the specification, in combination with another therapeutic agent and methods of using such combinations in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: April 22, 2002
    Date of Patent: October 4, 2005
    Assignee: Pfizer Inc.
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 6897310
    Abstract: Pharmaceutical compositions comprising compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are defined as in the specification, in combination with another therapeutic agent and methods of using such combinations in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: May 24, 2005
    Assignee: Pfizer Inc
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 6887884
    Abstract: Compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: May 3, 2005
    Assignee: Pfizer Inc
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 6605610
    Abstract: Compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: August 12, 2003
    Assignee: Pfizer Inc
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Publication number: 20030130260
    Abstract: This invention is directed to compounds of the formula (I): 1
    Type: Application
    Filed: January 3, 2003
    Publication date: July 10, 2003
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Publication number: 20030130261
    Abstract: This invention is directed to compounds of the formula (I): 1
    Type: Application
    Filed: January 3, 2003
    Publication date: July 10, 2003
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Publication number: 20020132824
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: April 23, 2002
    Publication date: September 19, 2002
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Publication number: 20020111350
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: April 22, 2002
    Publication date: August 15, 2002
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Patent number: 6410550
    Abstract: Compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are defined as in the specification, intermediates in the synthesis of such compounds. pharmaceutical compositions containing such compounds and methods of using such compounds, in the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: September 28, 1999
    Date of Patent: June 25, 2002
    Assignee: Pfizer INC
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks
  • Publication number: 20020072525
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: February 13, 2002
    Publication date: June 13, 2002
    Inventors: Jotham Wadsworth Coe, Paige Roanne Palmer Brooks